Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.
As she was deposited on our doorstep it was clear that she was absolutely terrified. Two years later, we've finally coaxed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback